The medical technology industry finds itself exposed to increasing regulations. The European regulations (Medical Device Regulation, MDR) and the Swiss provisions (Law on Therapeutic Products – HMG; Law on Human Research – HFG; Ordinance on Medical Devices – MepV) with entry into force on 26 May 2021 in particular are keeping the industry very busy. The expert group Regulatory Affairs (EG RA) provides the medical technology industry with its specialist knowledge and supports the Office in matters concerning Regulatory Affairs. The EG RA primarily acts as a platform for exchange for thematic working groups. In contrast, the Office performs the Association’s strategic tasks and ensures general communication with its members, the industry, the media and other stakeholders.